Recommendations for the management of Acanthamoeba keratitis

References

1. Agahan A. L., Lim R. B., Valenton M. J. 2009; Successful treatment of Acanthamoeba keratitis without anti-amoebic agents. Ann Acad Med Singapore 38:175–176[PubMed]
   [Google Scholar]
2. Baig A. M., Iqbal J., Khan N. A. 2013; In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype. Antimicrob Agents Chemother 57:3561–3567 [View Article][PubMed]
   [Google Scholar]
3. Clarke B., Sinha A., Parmar D. N., Sykakis E. 2012; Advances in the diagnosis and treatment of Acanthamoeba keratitis. J Ophthalmol 2012:484892 [View Article][PubMed]
   [Google Scholar]
4. Kataoka C., Egashira K., Ishibashi M., Inoue S., Ni W., Hiasa K., Kitamoto S., Usui M., Takeshita A. 2004; Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 286:H768–H774 [View Article][PubMed]
   [Google Scholar]
5. Nagington J., Watson P. G., Playfair T. J., Mcgill J., Jones B. R., Steele A. D. 1974; Amoebic infection of the eye. Lancet 304:1537–1540 [View Article][PubMed]
   [Google Scholar]
6. Olanow C. W., Koller W. C.American Academy of Neurology 1998; An algorithm (decision tree) for the management of Parkinson’s disease: treatment guidelines. Neurology 50:Suppl 3S1–S57 [View Article][PubMed]
   [Google Scholar]
7. Sharma S., Garg P., Rao G. N. 2000; Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108 [View Article][PubMed]
   [Google Scholar]
8. Stapleton F., Ozkan J., Jalbert I., Holden B. A., Petsoglou C., McClellan K. 2009; Contact lens-related Acanthamoeba keratitis. Optom Vis Sci 86:E1196–E1201 [View Article][PubMed]
   [Google Scholar]
9. Sweeney P. J. 1995; Parkinson’s disease: managing symptoms and preserving function. Geriatrics 50:24–31[PubMed]
   [Google Scholar]